BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20980345)

  • 1. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
    Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
    Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
    Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice.
    Hu Y; Le Leu RK; Young GP
    Int J Cancer; 2005 Oct; 116(6):870-5. PubMed ID: 15849741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice.
    Hu Y; Le Leu RK; Belobrajdic D; Young GP
    Mol Nutr Food Res; 2008 May; 52(5):558-66. PubMed ID: 18324704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer.
    Mladenova DN; Dahlstrom JE; Tran PN; Benthani F; Bean EG; Ng I; Pangon L; Currey N; Kohonen-Corish MR
    Dis Model Mech; 2015 Sep; 8(9):1093-103. PubMed ID: 26183215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite Instability in Mouse Models of Colorectal Cancer.
    Currey N; Daniel JJ; Mladenova DN; Dahlstrom JE; Kohonen-Corish MRJ
    Can J Gastroenterol Hepatol; 2018; 2018():6152928. PubMed ID: 29686976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
    Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis.
    Bousserouel S; Gosse F; Bouhadjar M; Soler L; Marescaux J; Raul F
    Oncol Rep; 2010 Feb; 23(2):511-7. PubMed ID: 20043115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
    Umesalma S; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):650-5. PubMed ID: 20406206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers in chemoprevention of colon cancer. Inhibition of expression of ras-p21 and p53 by sulindac during azoxymethane-induced colon carcinogenesis.
    Singh J; Reddy BS
    Ann N Y Acad Sci; 1995 Sep; 768():205-9. PubMed ID: 8526349
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.
    Kawamori T; Lubet R; Steele VE; Kelloff GJ; Kaskey RB; Rao CV; Reddy BS
    Cancer Res; 1999 Feb; 59(3):597-601. PubMed ID: 9973206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.